|Year : 2019 | Volume
| Issue : 2 | Page : 111-115
|Utility of DNA-specific stains in micronuclei assay as a marker of genotoxicity in oral potentially malignant disorders and oral squamous cell carcinoma
Saurabh Juneja, Sonal Katyal, Ajit Singh Rathore, Devi Charan Shetty, Ankita Tandon, Pankaj Jain
Department of Oral Pathology, I.T.S-CDSR, Ghaziabad, Uttar Pradesh, India
Click here for correspondence address and email
|Date of Web Publication||8-Mar-2019|
| Abstract|| |
Background: The term oral potentially malignant disorder (OPMD) was recommended to refer to precancer as it conveys that not all disorders described under this term may transform into cancer. Oral squamous cell carcinoma (OSCC) arises through an accumulation of genetic alterations, deoxy ribonucleic acid (DNA) changes, and epigenetic alterations. Thus, a simple yet a sensitive and specific test for early diagnosis is the need of an hour. The micronuclei (MN) assay in exfoliated epithelial cells is potentially an excellent biomarker to detect chromosome loss or malfunction of mitotic spindle. Aim of the Study: To compare the frequency of MN in exfoliated cells from oral mucosa exposed to genotoxic agents using different staining procedures and to observe the incidence of micronucleus in potentially malignant and malignant lesions. Materials and Methods: The study was undertaken to observe the cytogenetic damage in the exfoliated buccal cells of 75 cases of tobacco-related PMDs, OSCC and control subjects (25 cases from each group) and were evaluated with nonspecific May-Grünwald Giemsa stain and DNA-specific Feulgen stain. The results were statistically determined using SPSS version 17.0. Results: Correlation analyses in the present study depicted that MN frequency was significantly more in oral squamous cell carcinoma than OPMDs and normal group (P < 0.05). Giemsa-stained slides correlated significantly with karyorrhexis, karyolysis, condensed chromatin, and binucleates, whereas no such correlations were found with DNA-specific stains. Conclusion: Malignant transformation is accompanied by loss of cell capacity to evolve to death in situations of DNA damage. These findings indicate that nuclear anomalies may be misinterpreted as MN with nonspecific DNA stains and lead to false-positive results in studies with cells of epithelial origin.
Keywords: Feulgen stain, Giemsa stain, Oral potentially malignant disorders, Oral squamous cell carcinoma
|How to cite this article:|
Juneja S, Katyal S, Rathore AS, Shetty DC, Tandon A, Jain P. Utility of DNA-specific stains in micronuclei assay as a marker of genotoxicity in oral potentially malignant disorders and oral squamous cell carcinoma. J Cytol 2019;36:111-5
|How to cite this URL:|
Juneja S, Katyal S, Rathore AS, Shetty DC, Tandon A, Jain P. Utility of DNA-specific stains in micronuclei assay as a marker of genotoxicity in oral potentially malignant disorders and oral squamous cell carcinoma. J Cytol [serial online] 2019 [cited 2023 Mar 23];36:111-5. Available from: https://www.jcytol.org/text.asp?2019/36/2/111/251099
| Introduction|| |
Genomic damage is considered to be the most important cause of developmental and degenerative diseases. It is also well known that genetic damage is produced by genotoxins, various medical procedures that include radiation and chemicals, micronutrient deficiency, lifestyle factors, and genetic factors such as inherited defects in DNA metabolism or repair.
It is now well established that micronuclei (MN) mainly originate from a centric chromosome fragments, acentric chromatid fragments, or whole chromosomes that fail to be included in the daughter nuclei at the completion of telophase during mitosis because they did not attach properly with the spindle during the segregation process in anaphase. These displaced chromosomes or chromosome fragments are eventually enclosed by a nuclear membrane and, except for their smaller size, are morphologically similar to nuclei after conventional nuclear staining.
The proportion of basal cells and cells undergoing cell death in buccal mucosa is an indication of the regenerative capacity of this tissue. To evaluate the genotoxic risks, DNA damage can be assessed by cytogenetic markers such as chromosomal aberrations, sister chromatid exchanges, and MN assay which is employed to detect aneuploidy, chromosomal breaks, and changes in telomere length. MN are microscopically visible, round or oval cytoplasmic chromatin masses in the extranuclear vicinity that originate from aberrant mitosis.
MN were originally identified and described in erythrocytes by the hematologists William Howell and Justin Jolly and were later found to be associated with deficiencies in vitamins, such as folate and vitamin B12.
MN and other nuclear abnormalities are biomarkers of genotoxic events and chromosomal instability and are collectively measured in micronucleus cytome assay. The molecular mechanisms behind these events have been investigated using molecular probes and genetically engineered cells. The buccal cell micronucleus assay was proposed in 1983; thereafter it gained popularity as a biomarker of genetic damage in numerous applications. Peripheral blood lymphocytes have also been used for micronucleus approach in the past.
There are numerous staining methods out of which DNA-specific stains are ideal for staining. Among them, the most widely used are Feulgen reaction followed by counterstaining with fast green to delineate cell cytoplasm. Acridine orange can also be applied with MN fluorescing bright green. The other stains include diamidino-2-phenylindole, propidium iodide, Papanicolaou stain, Hoescht, May-Grünwald Giemsa stain, and orcein.
The turnover rate for the appearance of MN in exfoliated buccal cells in an otherwise normal cell after exposure to an acute genotoxic event was estimated to be a minimum of 5–7 days. As the intralaboratory and interlaboratory variations exist in studies for MN in exfoliated cells, efforts were made to standardize the assay. Because the first publications of Stich and Rosin are the basic criteria for identification of MN, a number of studies have been done by different authors to standardize the MN identification criteria.
Oral carcinomas are characterized by complex karyotypes that involve many chromosomal deletions, translocations, and structural abnormalities. Cells often have errors in chromosome segregation that lead to the formation of a lagging chromosome or chromosome parts that become lost during the anaphase stage of cell separation and are excluded from the reforming nuclei. The laggards are observed in the cytoplasm as MN.
The assessment of MN in exfoliated cells is a promising tool for the study of epithelial carcinogens and can be used to detect chromosome breakage or mitotic interference, thought to be relevant to carcinogenesis. The direct correlation between the MN formation and genomic damage makes the MN assay an efficient alteration to the metaphase analysis., It has been used in the detection of oral squamous cell carcinoma (OSCC) with 94% sensitivity, 100% specificity, and an accuracy of 95%.
It has been well established by researchers that virtually all oral cancers are preceded by visible clinical changes in the oral mucosa usually in the form of white or red patch. Prevention and early detection of such oral potentially malignant disorders (OPMDs) have the potential of not only decreasing the incidence but also improving the survival of those who develop oral cancer. OPMDs mainly include leukoplakia, erythroplakia, lichen planus, oral submucous fibrosis, which have the capability of transforming into malignancy if not caught at the right time.
Exfoliated buccal cells have been used noninvasively to show the genotoxic effects of lifestyle factors, such as tobacco smoking, chewing of betel quids, radiotherapy, and occupational exposure to potentially mutagenic and/or carcinogenic chemicals. Hence the present study was designed to compare the frequency of MN in exfoliated cells from oral mucosa exposed to genotoxic agents using DNA-specific (Feulgen) and nonspecific (Giemsa) stains and to determine the qualitative efficacy of both the stains in assessment of MN in exfoliated oral mucosal cells and clinicopathological correlation of MN frequency in exfoliated oral mucosal cells.
| Materials and Methods|| |
This cross-sectional and observational study comprised 150 smears from 75 cases (25 smears each from potentially malignant disorders, oral cancer, and healthy subjects) and the smears were taken from the subjects with a habit of chewing and smoking tobacco for a minimum of past 10 years to observe the cytogenetic damage in the exfoliated buccal cells and is evaluated with nonspecific Giemsa stain and DNA-specific Feulgen stain.
Subjects were asked to rinse their mouth thoroughly with water before the smear was taken. A wet wooden spatula was used to scrape the buccal mucosa vigorously from the patient's mouth. Scraped material was spread on the precleaned slides and fixed with Bio fix spray and air dried. Giemsa and Feulgen were used to stain the prepared slides and were viewed under light microscope at 100 × magnification (oil immersion) to count the MN, and 1000 cells were observed randomly at 100 × magnification using oil immersion.
MN were observed and recorded in exfoliated oral epithelial cells according to the criteria defined by Tolbert et al. Only those MN were scored, which were round or oval in shape with a smooth perimeter suggestive of membrane, less than one-third of the diameter of the main nucleus, of the same texture, color, and rarefaction as the main nucleus with no overlap or bridge to the nucleus. Mean number of MN and micronucleated cells were calculated and its ratio (i.e., micronucleus index) was also determined. Qualitative assessment was done by comparing DNA–specific (Feulgen) and nonspecific (Giemsa) stains using working parameters by Sujathan et al. as shown in [Table 1].
|Table 1: Working parameters for qualitative analysis of staining under light microscope|
Click here to view
The results were statistically evaluated using Statistical Package for the Social Sciences (SPSS) version 17.0. Suitable statistical tests of comparison were done. Categorical variables were analyzed with Chi-square test and Fisher's exact test. Statistical significance was taken as P ≤ 0.05. The data were analyzed using SPSS, version 17.
| Results|| |
There were 75 cases in the study groups (25 each in normal, OPMDs and OSCC). Clinicopathological profiling of the patients under study groups is presented in [Table 2]. The mean number of MN and MN cell frequency were higher in OSCC than OPMD and normal control group using Feulgen stain and Giemsa stain (statistically significant, P ≤ 0.05). The results of MN index in study groups were statistically nonsignificant, P > 0.05 [Table 3] and [Table 4]. Additional nuclear features such as binucleation, condensed chromatin, and karyorrhexis were seen in smears of patients with OSCC and OPMD [Figure 1].
|Table 2: Clinicopathological profiling of the patients under study groups|
Click here to view
|Table 3: Mean number of micronucleus and micronucleated cells using Feulgen stain|
Click here to view
|Table 4: Mean number of micronucleus and micronucleated cells using Giemsa stain|
Click here to view
|Figure 1: Photomicrographs of Giemsa- and Feulgen-stained buccal smears showing (a) micronuclei in Giemsa-stained buccal smears (×100); (b) Micronuclei in Feulgen-stained buccal smears (×100); (c) Binucleation in Giemsa-stained buccal factors (×100); (d) Binucleation in Feulgen-stained buccal smears (×100); (e) Karyorrhexis in Feulgen-stained buccal smears (×100); (f) Condensed chromatin in Giemsa-stained buccal smears (×100)|
Click here to view
Qualitative assessment comparing DNA–specific (Feulgen) and nonspecific (Giemsa) stains, Feulgen stain proved to be superior as compared to Giemsa stain in terms of background staining, overall staining, and nuclear characteristics [Table 5]. Age, gender, and site did not significantly affect the MN frequencies with any of the staining methods, and these variables had also no effect on the differences between OSCC and OPMD.
|Table 5: Qualitative assessment comparing DNA specific (Feulgen) and nonspecific (Giemsa) stains|
Click here to view
| Discussion|| |
Despite commendable progress in the prevention, detection, and treatment of a wide variety of solid tumor types, OSCC remains a significant health burden across the globe. OSCC is often first diagnosed at late stages of the disease (advanced regional disease and/or metastasis). Delayed diagnosis precludes successful treatment and favorable outcomes. Complexity of the cancer could be attributed to its altered expression, abnormal growth, and invasion of tissues and disruption of normal functioning, which probably results from genomic instabilities caused by various chemicals or environmental carcinogens/mutants. It is also well known that genetic damage is produced by genotoxins, various medical procedures that include radiation and chemicals, micronutrient deficiency, lifestyle factors, and genetic factors such as inherited defects in DNA metabolism or repair. In clinical practice, opportunities exist to identify patients with OPMDs, which precede the development of cancer.
Among various chairside investigations of the lesion at early stage is MN assay using exfoliative cytology. MN assay is a sensitive, noninvasive, and inexpensive technique that offers a very simple method for obtaining information on status of the epithelial cells, particularly DNA damage, proliferative potential of basal cells, and cell death, which can be performed using exfoliative cytology.
Although it has been shown that increased MN frequency is observed in the buccal cells of populations exposed to occupational and environmental insults, various lifestyle factors, radiation and oral cancer, but the magnitude of changes is usually relatively small. Simplicity, accuracy, multipotentiality, and large tissue applicability of the MN technology made it attractive in the past and will ensure a key role in the evaluation of mutagenicity and primary prevention in the future. The results of MN assays in exfoliated oral cells depend strongly on the staining methods.
In our cases much higher MN frequency were found in OSCC with non-DNA-specific (Giemsa) stains. The number of MN and micronucleated cells were higher when seen under Giemsa staining of the smear as compared to the Feulgen-stained slide of the same patient [Table 4].
Our observations regarding MN formation in oral cells is overestimated with Giemsa-based stains and is also supported by the results reported by Casartelli et al., who compared MN numbers after Giemsa and propidium iodide staining in cells from patients with different pathologies of the oral cavity (leukoplakia and squamous cell carcinomas). They found a threefold higher frequency of MN with Giemsa than with any other DNA-specific stain. Comparisons between Feulgen and propidium iodide showed that 3–4-fold higher frequencies are obtained with the latter stain. Although consistently positive results were obtained with Giemsa, negative results were obtained in most studies such as Sarto et al., Celik et al., and Wu et al. with DNA-specific stains. Qualitative assessment of the MN should be made based on the DNA-specific Feulgen stain and acridine orange stain. Non-DNA-specific stains give high false-positive results.
Increased frequency of MN in Giemsa-stained smears was due to keratin granules that are found in degenerated cells with nuclear anomalies. Because MGG is a DNA nonspecific stain, hence along with MN, few keratin granules also take up the stain giving false positively high counts. These round cytoplasmic bodies, which are formed as a consequence of cell injury, do not contain DNA and may be classified as MN with nonspecific stains.
| Conclusion|| |
Assessment of MN assay in potentially malignant and OSCC subjects can be used as an efficient marker for genotoxic damage. Hence, MN estimation using exfoliative cytology of the lesion as a chairside investigation should be done routinely in the clinics, as it provides promising results when analyzed using DNA-specific stains. Our observations indicate that the results of earlier MN studies in cells of epithelial origin should be interpreted with caution when nonspecific DNA stains were used.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Agarwal M, Dawar G, Rallan NS. Micronuclei assay of exfoliated oral mucosal cells: A review. Annal Dent Speciality 2014;2:47-50.
Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, et al.
Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 2011;26:125-32.
Bansal H, Sandhu VS, Bhandari R, Sharma D. Evaluation of micronuclei in tobacco users: A study in Punjabi population. Contemp Clin Dent 2012;3:184-7.
] [Full text]
Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, et al.
The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental protection agency gene-tox program. Mutat Res 1983;123:61-118.
Kashyap B, Reddy PS. Micronuclei assay of exfoliated oral buccal cells: Means to assess the nuclear abnormalities in different diseases. J Cancer Res Ther 2012;8:184-91.
Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: Methods development. Mutat Res 1992;271:69-77.
Sujathan K, Pillai RK, Kannan S, Chandralekha B, Mathew A, Nair KM. Cytodiagnosis of serous effusions: A combined approach to morphological features in Papanicolaou and May-Grünwald Giemsa stain and a modified cell block preparation. J Cytol 2000;17:89-95. [Full text]
Sivasankari P, Kaur S, Reddy KS, Vivekanandam S, Rao RK. Micronucleus index: An early diagnosis in oral carcinoma. J Anat Soc India 2008;57:8-13.
Casartelli G, Monteghirfo S, De Ferrari M, Bonatti S, Scala M, Toma S, et al.
Staining of micronuclei in squamous epithelial cells of human oral mucosa. Anal Quant Cytol Histol 1997;19:475-81.
Sarto F, Finotto S, Giacomelli L, Mazzotti D, Tomanin R, Levis AG, et al.
The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis 1987;2:11-7.
Celik A, Cavaş T, Ergene-Gözükara S. Cytogenetic biomonitoring in petrol station attendants: Micronucleus test in exfoliated buccal cells. Mutagenesis 2003;18:417-21.
Wu PA, Loh CH, Hsieh LL, Liu TY, Chen CJ, Liou SH, et al.
Clastogenic effect for cigarette smoking but not areca quid chewing as measured by micronuclei in exfoliated buccal mucosal cells. Mutat Res 2004;562:27-38.
Dr. Saurabh Juneja
Department of Oral Pathology, I.T.S-CDSR, Murad Nagar, Ghaziabad, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
|This article has been cited by|
||Is micronucleus assay in oral exfoliated cells a suitable biomarker for predicting cancer risk in individuals with oral potentially malignant disorders? A systematic review with meta-analysis
| ||Daniel Vitor de Souza, Barbara dos Anjos Rosario, Wilton Mitsunari Takeshita, Milena de Barros Viana, Marcia Regina Nagaoka, Jean Nunes dos Santos, Daniel Araki Ribeiro |
| ||Pathology - Research and Practice. 2022; : 153828 |
|[Pubmed] | [DOI]|
||Micronuclei and upper body cancers (head, neck, breast cancers) a systematic review and meta-analysis
| ||Claudia Bolognesi, Marco Bruzzone, Marcello Ceppi, Francesca Marcon |
| ||Mutation Research/Reviews in Mutation Research. 2021; 787: 108358 |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||3553 |
| Printed||112 |
| Emailed||0 |
| PDF Downloaded||236 |
| Comments ||[Add] |
| Cited by others ||2 |